MIF and Autoimmunity: Although these findings were in the context of autoimmunity (190), the more recent findings that patients that respond to ICB treatment have a higher intratumoral frequency of un-switched and switched memory (CD19+CD27+IgD−/+) B cells (181) suggests that further and more detailed investigation of whether/how MIF affects B cell class switching during tumorigenesis is warranted.